Clinical Trial Update: PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial is evaluating PurIST classification-guided adaptive neoadjuvant chemotherapy for pancreatic cancer using RNA expression profiling of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Pancreatic Cancer | Phase 2 | Status: RECRUITING